Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?

Published: 20 Apr 2019 | Version 1 | DOI: 10.17632/dhjfv9n8d2.1

Description of this data

Summary of EviQ (Australian) chemotherapy protocols that recommend a platinum drug (Cisplatin, carboplatin, oxaliplatin).

Experiment data files

This data is associated with the following publication:

Platinum drugs in the Australian cancer chemotherapy healthcare setting: Is it worthwhile for chemists to continue to develop platinums?

Published in: Inorganica Chimica Acta

Latest version

  • Version 1

    2019-04-20

    Published: 2019-04-20

    DOI: 10.17632/dhjfv9n8d2.1

    Cite this dataset

    Wheate, Nial; Armstrong-Gordon, Evangeline; Um, Irene; Gnjidic, Danijela; Moussa, Yvonne (2019), “Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?”, Mendeley Data, v1 http://dx.doi.org/10.17632/dhjfv9n8d2.1

Statistics

Views: 132
Downloads: 10

Categories

Oncology

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?
You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report